cnbc.comStocks making the biggest moves midday: Tesla, Novo Nordisk, Hims & Hers, Northern Trust, Fiserv and more23 days ago
benzinga.comExelixis Targets $5 Billion In Sales With Promising Data In Key Colorectal Cancer Drug Trial, Stock Soars23 days ago
foxnews.comNew study exposes green energy org's ties to CCP interests while undermining USabout 1 month ago
zerohedge.comBayer's Push For State-Level Roundup Immunity Sparks Backlash In The Heartlandabout 1 month ago
prnewswire.comGalmed Announces First Time Results in Oncology Studies: Aramchol Significantly Enhances Bayer's Regorafenib Effect in GI Cancer Models2 months ago
cnbc.comCorporate America shelled out millions for Trump's inauguration. Now he's upending many of their businesses3 months ago
prnewswire.comNew Research from CreativeX Reveals $47.8 Billion in Potential Advertising Efficiencies3 months ago
CashuExelixis Advances Cancer Treatment: STELLAR-303 Trial Results Impress Amid Bayer AG Market Trends22 days ago
CashuExelixis' Zanzalintinib Shows Promise in Phase 3 RCC Trial Amid Bayer AG Stock Fluctuations24 days ago